Regen BioPharma RGBP
OTC RGBP
$0.00 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Regen BioPharma Inc (RGBP) EBIT (2013 - 2026)

Updated

Regen BioPharma (RGBP) reported EBIT of -$637,785 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$40,756 a year earlier.

Analysis

Regen BioPharma Inc (RGBP) EBIT (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Regen BioPharma's EBIT came in at -$1.35 million; for FY2025 (ended Sep 30, 2025), it came in at -$338,540.

  • By fiscal year, EBIT came in at -$417,221 in FY2024, -$686,950 in FY2023, -$339,605 in FY2022 and -$200,771 in FY2021.
  • The fiscal Q3 2026 figure ranks as the lowest quarterly EBIT since fiscal Q1 2018.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -637,785.00
Dec 31, 2025 -551,624.00
Sep 30, 2025 -123,055.00
Jun 30, 2025 -40,756.00
Mar 31, 2025 -113,349.00
Dec 31, 2024 -61,378.00
Sep 30, 2024 -85,402.00
Jun 30, 2024 -107,966.00
Mar 31, 2024 -101,071.00
Dec 31, 2023 -122,782.00
Sep 30, 2023 -59,087.00
Jun 30, 2023 -85,155.00
Mar 31, 2023 -78,842.00
Dec 31, 2022 -463,867.00
Sep 30, 2022 -97,779.00
Jun 30, 2022 -58,910.00
Mar 31, 2022 -76,494.00
Dec 31, 2021 -106,422.00
Sep 30, 2021 -126,826.00
Jun 30, 2021 -42,491.00
API Access

Regen BioPharma Inc EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=RGBP&period=max&api_key=YOUR_API_KEY